Table 3.
Clinical characteristics in male subjects by race/ethnicity
| Variable | All | Caucasian | African American | Hispanic | American Indian | Asian American | Other |
|---|---|---|---|---|---|---|---|
| Number | 2081 | 1581 | 190 | 196 | 55 | 16 | 41 |
| Age (yrs) | |||||||
| 524 (25.2%) | 371 (23.5%) | 57 (30.0%) | 58 (29.6%) | 24 (43.6%) | 4 (25.0%) | 9 (22.0%) | |
| 1115 (53.6%) | 859 (54.3%) | 92 (48.4%) | 109 (55.6%) | 22 (40.0%) | 9 (56.3%) | 23 (56.1%) | |
| 442 (21.2%) | 351 (22.2%) | 41 (21.6%) | 29 (14.8%) | 9 (16.4%) | 3 (18.8%) | 9 (22.0%) | |
| BMI (kg/m2) | |||||||
| 25 – 27 | 46 (2.2%) | 32 (2.0%) | 5 (2.6%) | 3 (1.5%) | 3 (5.5%) | 2 (12.5%) | 1 (2.4%) |
| 27 – 30 | 294 (14.1%) | 216 (13.7%) | 23 (12.1%) | 29 (14.8%) | 11 (20.0%) | 9 (56.3%) | 6 (14.6%) |
| 30 – 35 | 833 (40.0%) | 623 (39.4%) | 72 (37.9%) | 92 (46.9%) | 26 (47.3%) | 4 (25.0%) | 15 (36.6%) |
| 35 – 40 | 535 (25.7%) | 417 (26.4%) | 51 (26.8%) | 41 (20.9%) | 9 (16.4%) | 1 (6.3%) | 16 (39.0%) |
| >= 40 | 372 (17.9%) | 292 (18.5%) | 39 (20.5%) | 31 (15.8%) | 6 (10.9%) | 0 (0.0%) | 3 (7.3%) |
| Blood Pressure (mmHg) | |||||||
| Systolic | 128.52 ± 16.57 | 128.70 ± 16.78 | 128.72 ± 15.81 | 128.37 ± 15.51 | 124.51 ± 14.40 | 123.97 ± 19.03 | 128.24 ± 18.59 |
| Diastolic | 73.21 ± 9.17 | 72.65 ± 9.02 | 75.49 ± 9.52 | 74.25 ± 9.09 | 76.17 ± 7.96 | 75.43 ± 12.76 | 74.36 ± 11.15 |
| Antihypertensive medication, n (%) | 1450 (69.7%) | 1121 (70.9%) | 136 (71.6%) | 127 (64.8%) | 30 (54.5%) | 8 (50.0%) | 27 (65.9%) |
| Fasting plasma glucose (mg/dl) | 156.07 ± 46.12 | 157.70 ± 45.65 | 146.89 ± 49.91 | 156.70 ± 46.13 | 150.28 ± 46.33 | 140.60 ± 42.37 | 147.21 ± 42.61 |
| HbA1c (%) | |||||||
| < 6.0 | 170 (8.4%) | 129 (8.4%) | 13 (7.0%) | 19 (9.8%) | 5 (10.0%) | 1 (6.7%) | 2 (5.1%) |
| 6.0 – 6.5 | 344 (17.0%) | 265 (17.3%) | 27 (14.4%) | 30 (15.5%) | 7 (14.0%) | 3 (20.0%) | 11 (28.2%) |
| 6.5 – 7.0 | 410 (20.3%) | 337 (22.0%) | 29 (15.5%) | 25 (13.0%) | 7 (14.0%) | 4 (26.7%) | 8 (20.5%) |
| 7.0 – 8.0 | 619 (30.6%) | 468 (30.5%) | 56 (29.9%) | 64 (33.2%) | 16 (32.0%) | 4 (26.7%) | 11 (28.2%) |
| 8.0 – 9.0 | 317 (15.7%) | 233 (15.2%) | 38 (20.3%) | 33 (17.1%) | 8 (16.0%) | 1 (6.7%) | 4 (10.3%) |
| > 9.0 | 161 (8.0%) | 103 (6.7%) | 24 (12.8%) | 22 (11.4%) | 7 (14.0%) | 2 (13.3%) | 3 (7.7%) |
| Plasma lipids (mg/dl) | |||||||
| Total cholesterol | 182.20 ± 36.22 | 182.02 ± 36.23 | 185.14 ± 37.83 | 185.90 ± 36.58 | 170.30 ± 34.50 | 176.87 ± 27.86 | 175.13 ± 27.87 |
| HDL cholesterol | 38.05 ± 9.09 | 37.64 ± 8.79 | 42.22 ± 10.62 | 37.09 ± 8.57 | 36.50 ± 8.85 | 42.80 ± 11.94 | 39.79 ± 8.68 |
| LDL cholesterol | 107.07 ± 30.61 | 106.12 ± 30.12 | 115.45 ± 32.46 | 109.37 ± 33.45 | 98.66 ± 29.58 | 98.00 ± 19.35 | 107.13 ± 23.98 |
| Triglycerides | 192.01 ± 129.75 | 198.20 ± 129.64 | 141.98 ± 121.38 | 203.92 ± 138.28 | 181.20 ± 99.60 | 200.67 ± 184.31 | 142.54 ± 70.65 |
| Lipid-lowering medication, n (%) | 1148 (55.2%) | 935 (59.1%) | 84 (44.2%) | 79 (40.3%) | 21 (38.2%) | 8 (50.0%) | 20 (48.8%) |
| CVD History, n (%) | 442 (21.2%) | 362 (22.9%) | 26 (13.7%) | 29 (14.8%) | 10 (18.2%) | 4 (25.0%) | 11 (26.8%) |